AbstractA high-yield production of a peptide vaccine in transgenic plants is described here. A 21-mer peptide, which confers protection to dogs against challenge with virulent canine parvovirus, has been expressed in transgenic plants as an amino-terminal translational fusion with the GUS gene. Transformants were selected on the basis of their GUS activities, showing expression levels of the recombinant protein up to 3% of the total leaf soluble protein, a production yield comparable to that obtained with the same epitope expressed by chimeric plant viruses. The immunogenicity of the plant-derived peptide was demonstrated in mice immunized either intraperitoneally or orally with transgenic plant extracts, providing the suitability of the GU...
Transgenic plants offer many advantages, including low cost of production (by elimination of ferment...
Plant-produced vaccines are a much-hyped development of the past two decades, whose time to embrace ...
The oral vaccines and oral vaccine adjuvants of the present invention are produced in transgenic pla...
AbstractA high-yield production of a peptide vaccine in transgenic plants is described here. A 21-me...
The 2L21 peptide, which confers protection to dogs against challenge with virulent canine parvovirus...
Plants present a cost effective production system for high value proteins. There is an increasing wo...
Peptides have unique properties that make them useful drug candidates for diverse indications, inclu...
The expression of antigens in transgenic plants has been increasingly used as an alternative to the ...
Molecular farming technology offers a unique advantage that almost any protein can be produced econo...
The vaccines are very effective vehicles for the prevention of various diseases. The cost of product...
Plants have been identified as promising expression systems for the commercial production of vaccine...
Plants have been identified as promising expression systems for commercial production of vaccine ant...
Initially, subunit vaccines were based on toxins purified from culture supernatants of host organism...
Vaccines and antibodies play a key role in healthcare. However, the cost of production and maintaini...
In the last few years, plants have become an increasingly attractive platform for recombinant protei...
Transgenic plants offer many advantages, including low cost of production (by elimination of ferment...
Plant-produced vaccines are a much-hyped development of the past two decades, whose time to embrace ...
The oral vaccines and oral vaccine adjuvants of the present invention are produced in transgenic pla...
AbstractA high-yield production of a peptide vaccine in transgenic plants is described here. A 21-me...
The 2L21 peptide, which confers protection to dogs against challenge with virulent canine parvovirus...
Plants present a cost effective production system for high value proteins. There is an increasing wo...
Peptides have unique properties that make them useful drug candidates for diverse indications, inclu...
The expression of antigens in transgenic plants has been increasingly used as an alternative to the ...
Molecular farming technology offers a unique advantage that almost any protein can be produced econo...
The vaccines are very effective vehicles for the prevention of various diseases. The cost of product...
Plants have been identified as promising expression systems for the commercial production of vaccine...
Plants have been identified as promising expression systems for commercial production of vaccine ant...
Initially, subunit vaccines were based on toxins purified from culture supernatants of host organism...
Vaccines and antibodies play a key role in healthcare. However, the cost of production and maintaini...
In the last few years, plants have become an increasingly attractive platform for recombinant protei...
Transgenic plants offer many advantages, including low cost of production (by elimination of ferment...
Plant-produced vaccines are a much-hyped development of the past two decades, whose time to embrace ...
The oral vaccines and oral vaccine adjuvants of the present invention are produced in transgenic pla...